Impact of TP53 Mutation Status in Elderly AML Patients When Adding All-Trans Retinoic Acid or Valproic Acid to Decitabine.

Bresser H, Schmoor C, Grishina O, Pfeifer D, Thomas J, Rehman UU, Crysandt M, Jost E, Thol F, Heuser M, Götze KS, Schlenk RF, Salih HR, Schittenhelm MM, Heil G, Schwaenen C, Müller-Tidow C, Brugger W, Kündgen A, de Wit M, Giagounidis A, Scholl S, Neubauer A, Krauter J, Bug G, May AM, Wäsch R, Duyster J, Döhner K, Ganser A, Döhner H, Hackanson B, Becker H, Lübbert M

Open source

DOI
10.1111/ejh.14304
Published
2025 Feb
Container
European journal of haematology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/ejh.14304,
  title = {Impact of TP53 Mutation Status in Elderly AML Patients When Adding All-Trans Retinoic Acid or Valproic Acid to Decitabine.},
  author = {Bresser H and Schmoor C and Grishina O and Pfeifer D and Thomas J and Rehman UU and Crysandt M and Jost E and Thol F and Heuser M and Götze KS and Schlenk RF and Salih HR and Schittenhelm MM and Heil G and Schwaenen C and Müller-Tidow C and Brugger W and Kündgen A and de Wit M and Giagounidis A and Scholl S and Neubauer A and Krauter J and Bug G and May AM and Wäsch R and Duyster J and Döhner K and Ganser A and Döhner H and Hackanson B and Becker H and Lübbert M},
  year = {2025},
  journal = {European journal of haematology},
  doi = {10.1111/ejh.14304},
  url = {https://doi.org/10.1111/ejh.14304}
}

RIS

TY  - JOUR
TI  - Impact of TP53 Mutation Status in Elderly AML Patients When Adding All-Trans Retinoic Acid or Valproic Acid to Decitabine.
AU  - Bresser H
AU  - Schmoor C
AU  - Grishina O
AU  - Pfeifer D
AU  - Thomas J
AU  - Rehman UU
AU  - Crysandt M
AU  - Jost E
AU  - Thol F
AU  - Heuser M
AU  - Götze KS
AU  - Schlenk RF
AU  - Salih HR
AU  - Schittenhelm MM
AU  - Heil G
AU  - Schwaenen C
AU  - Müller-Tidow C
AU  - Brugger W
AU  - Kündgen A
AU  - de Wit M
AU  - Giagounidis A
AU  - Scholl S
AU  - Neubauer A
AU  - Krauter J
AU  - Bug G
AU  - May AM
AU  - Wäsch R
AU  - Duyster J
AU  - Döhner K
AU  - Ganser A
AU  - Döhner H
AU  - Hackanson B
AU  - Becker H
AU  - Lübbert M
PY  - 2025
JO  - European journal of haematology
DO  - 10.1111/ejh.14304
UR  - https://doi.org/10.1111/ejh.14304
ER  - 

APA

H, B., C, S., O, G., D, P., J, T., UU, R., M, C., E, J., F, T., M, H., KS, G., RF, S., HR, S., MM, S., G, H., C, S., C, M., W, B., A, K., M, D. W., A, G., S, S., A, N., J, K., G, B., AM, M., R, W., J, D., K, D., A, G., H, D., B, H., H, B., & M, L. (2025). Impact of TP53 Mutation Status in Elderly AML Patients When Adding All-Trans Retinoic Acid or Valproic Acid to Decitabine.. European journal of haematology. https://doi.org/10.1111/ejh.14304

Source records